Table 1.

The effect of cholesterol molar ratio and charge inducers on the encapsulation efficiency of fluconazole into multilamellar liposomes.

Liposome composition (molar ratio)	Charge	Encapsulation efficiency (% ±S.D.)
Phosphatidylcholine	Neutral	23.104 ± 0.197
Phosphatidylcholine:cholesterol (1:0.6)	Neutral	44.675 ± 0.324
Phosphatidylcholine:cholesterol:stearylamine (1:0.6:0.1)	Positive	52.657 ± 0.231
Phosphatidylcholine:cholesterol:dicetyl phosphate (1:0.6:0.1)	Negative	38.877 ± 0.164
Phosphatidylcholine:cholesterol (1:0.8)	Neutral	50.236 ± 0.335
Phosphatidylcholine:cholesterol:stearylamine (1:0.8:0.1)	Positive	59.998 ± 0.194
Phosphatidylcholine:cholesterol:dicetyl phosphate(1:0.8:0.1)	Negative	43.533 ± 0.244